Document 0812 DOCN M9620812 TI Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. DT 9602 AU Dighe AS; Campbell D; Hsieh CS; Clarke S; Greaves DR; Gordon S; Murphy KM; Schreiber RD; Center for Immunology, Washington University School of Medicine,; St. Louis, Missouri 63110, USA. SO Immunity. 1995 Nov;3(5):657-66. Unique Identifier : AIDSLINE MED/96074241 AB The ubiquitous cellular distribution of certain cytokine receptors has hampered attempts to define the physiologically important cell-specific functions of cytokines in vivo. Herein, we report the generation of transgenic mice that express a dominant-negative IFN gamma receptor alpha chain mutant under the control of either the human lysozyme promoter or the murine lck proximal promoter, which display tissue-specific unresponsiveness in the macrophage or T cell compartments, respectively, to the pleiotropic cytokine, IFN gamma. We utilize these mice to identify previously undefined cellular targets of IFN gamma action in the development of a murine antimicrobial response and the mixed lymphocyte reaction. Moreover, we identify the macrophage as a critical responsive cell in manifesting the effects of IFN gamma in regulating CD4+ T helper subset development. These studies thus represent a novel approach to studying the cell-specific actions of an endogenously produced pleiotropic cytokine in vivo. DE Animal B-Lymphocytes/DRUG EFFECTS Cell Differentiation/DRUG EFFECTS Female Human Interferon Type II/*PHARMACOLOGY Interleukin-12/BIOSYNTHESIS Killer Cells, Natural/DRUG EFFECTS Macrophages, Peritoneal/*DRUG EFFECTS/METABOLISM Mice Mice, Inbred BALB C Mice, Inbred C3H Mice, Inbred C57BL Mice, Transgenic Neutrophils/DRUG EFFECTS Organ Specificity/PHYSIOLOGY Receptors, Interferon/BIOSYNTHESIS/*DRUG EFFECTS Recombinant Proteins/PHARMACOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Th1 Cells/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).